A specific Medicare Advantage plan has sparked confusion online after a new deductible took effect this year. The Cigna True ...

In a report released today, Jailendra Singh from Truist Financial reiterated a Buy rating on Cigna (CI – Research Report), with a price target ...

The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this ...

In a report released today, Jessica Tassan from Piper Sandler maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...

Cigna Group closed 20.66% short of its 52-week high of $370.83, which the company reached on September 16th.

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Cigna Group closed 23.69% below its 52-week high of $370.83, which the company reached on September 16th.